A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome
Clinical trial NCT00916227 · COMPLETED
Trial details
- NCT number
- NCT00916227
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2012-01-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.